Amgen (AMGN) director Charles Holley receives stock award and reports trust holdings
Rhea-AI Filing Summary
AMGEN INC director Charles M. Holley reported a compensation-related acquisition of 103.4189 shares of common stock on 2026-08-07, recorded at a price of $0.0000 per share. Following this grant, he holds 12,990.4520 shares directly, which include 1,652 Dividend Equivalents credited to unvested Restricted Stock Units under Amgen’s equity incentive plan. He also reports 1,260.0000 shares held indirectly through the Holley Family Trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 103.4189 shares
Net Buy
2 txns
Insider
HOLLEY CHARLES M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 103.4189 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 12,990.452 shares (Direct);
Common Stock — 1,260 shares (Indirect, Holley Family Trust)
Footnotes (1)
- F1. These shares include 1,652 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Key Figures
Shares granted: 103.4189 shares
Direct holdings after transaction: 12,990.4520 shares
Indirect holdings via trust: 1,260.0000 shares
+2 more
5 metrics
Shares granted
103.4189 shares
Grant or award of Amgen common stock on 2026-08-07
Direct holdings after transaction
12,990.4520 shares
Direct Amgen common stock held by Charles M. Holley after award
Indirect holdings via trust
1,260.0000 shares
Amgen common stock held indirectly through Holley Family Trust
Dividend Equivalents included
1,652
DEs credited to unvested RSUs, paid one-to-one in shares at vesting
Award price per share
$0.0000
Reported price for the 103.4189-share grant
Key Terms
Dividend Equivalents, Restricted Stock Units, qualifying dividend reinvestment plan, indirect, +1 more
5 terms
Dividend Equivalents financial
"These shares include 1,652 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc."
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
Restricted Stock Units financial
"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
qualifying dividend reinvestment plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan"
indirect financial
"shares following transaction 1260.0000, direct_or_indirect I, nature_of_ownership Holley Family Trust"
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did AMGEN (AMGN) director Charles M. Holley report in this Form 4?
Charles M. Holley reported a grant of 103.4189 shares of Amgen common stock on 2026-08-07. After the award, he held 12,990.4520 direct shares and 1,260.0000 indirect shares via the Holley Family Trust.
What type of transaction is reported for AMGEN (AMGN) director Charles M. Holley?
The Form 4 shows a grant or award acquisition (code A) of 103.4189 shares of Amgen common stock. It is a compensation-related award, not an open-market purchase or sale, and is reported at a price of $0.0000 per share.
What are the Dividend Equivalents noted in Charles M. Holley’s AMGEN (AMGN) holdings?
Holley’s direct holdings include 1,652 Dividend Equivalents (DEs) granted under Amgen’s equity incentive plan. DEs are credited to unvested RSUs and paid in one share per DE at vesting, plus cash for any fractional amount.
How are Charles M. Holley’s indirect AMGEN (AMGN) holdings structured?
The Form 4 lists 1,260.0000 shares of Amgen common stock held indirectly through the Holley Family Trust. This reflects shares attributed to Holley via the trust, separate from his directly held and RSU-related shares.